Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In patients with R/R Primary mediastinal B-cell lymphoma (PMBCL), the combination of Brentuximab vedotin + Nivolumab represents a promising option, with high antitumor activity and a manageable safety profile.
…